0001209191-16-091520.txt : 20160114 0001209191-16-091520.hdr.sgml : 20160114 20160114190320 ACCESSION NUMBER: 0001209191-16-091520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160112 FILED AS OF DATE: 20160114 DATE AS OF CHANGE: 20160114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tobira Therapeutics, Inc. CENTRAL INDEX KEY: 0001311596 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030422069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-6625 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Tibira Therapeutics, Inc. DATE OF NAME CHANGE: 20150506 FORMER COMPANY: FORMER CONFORMED NAME: Regado Biosciences Inc DATE OF NAME CHANGE: 20041215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEBER ECKARD CENTRAL INDEX KEY: 0001279800 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35953 FILM NUMBER: 161343840 MAIL ADDRESS: STREET 1: C/O DOMAIN ASSOCIATES STREET 2: ONE PALO SQ CITY: PRINCETON STATE: NJ ZIP: 08542 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-12 0 0001311596 Tobira Therapeutics, Inc. TBRA 0001279800 WEBER ECKARD C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOUEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Options (right to buy) 7.91 2016-01-12 4 A 0 17778 0.00 A 2026-01-11 Common Stock 17778 17778 D The shares will vest ratably over 12 months of continuous service beginning on January 1, 2016, subject to the terms of the Issuer's 2013 Equity Compensation Plan. /s/ Brian Savage, attorney-in-fact 2016-01-14